HIV Prevention in Healthy Women: Safety and Pharmacokinetics of a Potential New Tenofovir Alafenamide Fumarate (TAF)-based Oral PrEP Regimen

HIV Prevention in Healthy Women: Safety and Pharmacokinetics of a Potential New Tenofovir Alafenamide Fumarate (TAF)-based Oral PrEP Regimen Meeting Abstract

authors

publication date

October 1, 2018

webpage

Web of Science

published in

AIDS RESEARCH AND HUMAN RETROVIRUSES Journal

start page

56

end page

56

volume

34